TGA investigates liver injury potential of Valerian

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

TGA = Therapeutic Goods Administration
including yellowing of the skin or eyes, dark urine, nausea, vomiting, unusual tiredness, weakness, stomach or abdominal pain and/or loss of appetite.

Therapeutic Goods Administration. Valerian (Valeriana officinalis): safety advisory - potential for liver injury. Internet Document : [2 pages], 15 Oct 2020. Available from: URL: https://www.tga.gov.au/alert/valerian-valeriana-officinalis

TGA investigates liver injury potential of Valerian. Reactions Weekly 1828, 4 (2020). https://doi.org/10.1007/s40278-020-85080-y

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.